Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Nguyen AnhCo
President and CEO at Atara Biotherapeutics. Filing since 16 Aug 2023.
CIK 0001977970
Company
Date
Role
Action
Shares
Amount
Of holding
ATRA
Atara Biotherapeutics, Inc.
17 Aug 2026
President and CEO
Sold at will
5,062
$40.88K
3.7%
ATRA
Atara Biotherapeutics, Inc.
18 May 2026
President and CEO
Sold at will
5,241
$47.84K
3.7%
ATRA
Atara Biotherapeutics, Inc.
2 Mar 2026
President and CEO
Sold at will
2,996
$15.24K
4.6%
ATRA
Atara Biotherapeutics, Inc.
17 Nov 2025
President and CEO
Sold at will
2,915
$38.44K
4.3%
ATRA
Atara Biotherapeutics, Inc.
18 Aug 2025
President and CEO
Sold at will
2,958
$34.36K
4.2%
ATRA
Atara Biotherapeutics, Inc.
16 May 2025
President and CEO
Sold at will
3,276
$22.16K
4.4%
ATRA
Atara Biotherapeutics, Inc.
3 Mar 2025
President and CEO
Sold at will
3,331
$23.31K
4.3%
ATRA
Atara Biotherapeutics, Inc.
18 Nov 2024
President and CEO
Sold at will
1,664
$18.63K
2.1%
ATRA
Atara Biotherapeutics, Inc.
16 Aug 2024
EVP, Chief Sci. & Tech Officer
Sold at will
1,821
$12.07K
5.1%
ATRA
Atara Biotherapeutics, Inc.
16 May 2024
EVP, Chief Sci. & Tech Officer
Sold at will
42,899
$26.47K
4.6%
ATRA
Atara Biotherapeutics, Inc.
4 Mar 2024
EVP, Chief Sci. & Tech Officer
Sold at will
10,746
$7.74K
1.1%
ATRA
Atara Biotherapeutics, Inc.
16 Nov 2023
EVP, Chief Sci. & Tech Officer
Sold at will
8,856
$3.44K
3.1%
ATRA
Atara Biotherapeutics, Inc.
16 Aug 2023
EVP, Chief Sci. & Tech Officer
Sold at will
15,126
$25.00K
5.0%
13 decisions on file.
